OssDsign AB (publ) (OSSD) Q2 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Hello and welcome to OsterSign's Q2 presentation. My name is Elvin Older, I work here at D&B Carnegie and I will be moderating today's presentation. I'm joined here by Mark Vo, the CEO of OsterSign and Anders Svensson, the CFO. I will now leave the word to the OsterSign team for their presentation. Thank you. Good morning, everyone. This is Mark Waugh, and I'm the CEO of Ost Design. And if you're new to our quarterly calls, I'll mention again that I joined the company January of this year. I also have our CFO, Andrew Svensson, with me today. And we're going to walk you through our second quarter 2026 results. As always, when we do these presentations, the normal disclaimer. Moving into our Q2 2026 highlights. For the quarter, AusDesign sales of SEC 37.8 million, or approximately USD 4 million, were essentially flat versus Q1 sales performance, and that was in line with my prior guidance. On a year-over-year comparables basis, Q2 translated to a 16% decline in constant currency terms, although that was on a very challenging comparable driven by some large bulk orders occurring in the last day of that same 2025 period. Gross margin and EBIT both improved for the quarter versus Q1. I'll let Anders cover the details on those after I finish with these highlights. And the science behind Catalyst and the results we continue to publish remain strong. I've mentioned before that our preclinical and our clinical data were two of the biggest reasons I joined the company. We continue to share that data with our customers during the Southernmost Spine and the International Society for the Advancement of Spine Surgery meetings recently. Additionally, on June 3rd, Ost Design shared the publication of a new scientific article in the Journal of Bone and Mineral Research, or JBMR. This...